echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Quantitative analysis of SPECT autopsy confirmed cases in patients with Lewy body dementia, Parkinson's disease and Alzheimer's disease

    JNNP: Quantitative analysis of SPECT autopsy confirmed cases in patients with Lewy body dementia, Parkinson's disease and Alzheimer's disease

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Management diagnosis consensus The purpose of this study is to use in vivo 123 I-FP-CIT (brain SPECT quantitative analysis to reassess the degree of differentiation of patients with DLB, AD, and PD on the basis of neuropathological diagnosis.


    The purpose of this study is to use in vivo 123 I- FP-CIT (quantitative brain SPECT analysis, reassess the differentiation of patients with DLB, AD and PD on the basis of neuropathological diagnosis.
    123 123 123 Vascular 123 123 I-FP-CIT brain SPECT quantitative analysis differentiates DLB, PD and AD The diagnosis has high accuracy.
    123 OliveiraFPM ,WalkerZ ,WalkerRWH OliveiraFPM Oliveira WalkerZ Walker WalkerRWH Walker , et al bmj.
    com/content/early/2021/02/09/jnnp-2020-324606" target="_blank" rel="noopener">123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases 123 Journal of Neurology, Neurosurgery & PsychiatryPublished Online First Published:04 February 2021.
    Online First: doi:10.
    1136/ jnnp-2020-324606 doi: leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.